IntelGenx Announces Definitive Agreement with Chemo Group for a Generic CNS Tablet
SAINT-LAURENT, CANADA--(Marketwired - Jan 4, 2017) - IntelGenx Corp., (TSX VENTURE:IGX) (OTCQX:IGXT), today announced the signing of a definitive agreement with Chemo Group ("Chemo") for the co-development and commercialization of a generic …